Many neurological diseases, such as Alzheimer's, Parkinson's, and brain tumors, require treatments that can effectively reach the brain. Traditional drug delivery methods often fail to cross the BBB, leading to ineffective treatments. Thus, developing strategies to cross the BBB is crucial for therapeutic advancements.
